MEDPLUSMedplus Health Services Limited

Rs 621.45▲ +2.19%
Market closedEquity EOD 27 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.10.1% up the range
Rs 576Rs 1,022
MEDPLUS price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 27 Oct
IndicatorsVolume

Loading MEDPLUS price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 7,306 cr
Larger than 63% of 41 peers
sector middle Rs 4,831 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
34.7x
Around the middle of 30 peers
sector middle 42.5x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
3.7x
Around the middle of 39 peers
sector middle 3.9x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
10.7%
Around the middle of 38 peers
sector middle 9.9%
FY23 3.4%FY26 11.1%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
12.2%
Higher than 56% of 34 peers
sector middle 11.6%
FY23 5.6%FY26 12.2%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.00
No borrowings
sector middle 0.06
FY23 0.00FY26 0.00
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 27% of 41 peers
sector middle 0.0%
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
+21.8%
Higher than 71% of 38 peers
sector middle +13.1%

Peers are the listed companies in the exchange's own industry group: Pharmacy Retail. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 21 Jul 2026), sales rose 21.8% from a year earlier to Rs 1,880 cr and profit fell 21.7% to Rs 33.2 cr.

Going well
  • No borrowings at the FY26 balance sheet.
  • Cash from operations was at least the reported profit in each of FY24, FY25, FY26.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 17 results, the share rose on 12 and fell on 5, and moved by 3% or more on 10.

Q3 FY22Q3 FY23Q4 FY24Q1 FY26Q1 FY27

Q1 FY27: results filed 21 Jul 2026. The share went from its close on 20 Jul 2026 to its close on 22 Jul 2026 -13.65%.

Where every Rs 100 of sales goes
From the company's own yearly results. Each year is scaled to that year's sales, so you compare shares, not size: how much went on running costs, depreciation, interest and tax, and how much was left as profit.
3 financial years
Sales, last 12 months
Rs 7,229 Cr
Profit, last 12 months
Rs 210 Cr
Earnings per share
Rs 17.5
Profit growth (qtr, YoY)
-21.67%

Of every Rs 100 of sales in FY26, Rs 91 went on running costs, Rs 4.1 on depreciation, Rs 1.7 on interest and Rs 0.8 on tax; Rs 3.2 was left as profit.

FY23
94
FY25
92
FY26
91
Sales (Rs 100)Other incomeRunning costsDepreciationInterestTaxProfit

Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.

How fast it has grown
Compound growth per year in sales, profit and earnings per share between financial years, from the company's own results. A span appears only if our filings cover both ends of it.
Sales
3 yrs
+14.8%/yr
Latest qtr
+21.8%
Profit
3 yrs
+63.7%/yr
Latest qtr
-21.7%

Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.

Health check, year by year
Margins, returns, debt and interest cover for each financial year. Each row is coloured against this company's own usual level, so you see what is improving and what is slipping.
MeasureFY23FY24FY25FY26
Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales.5.8%-7.8%8.8%
Net marginProfit after everything, per Rs 100 of sales.1.1%-2.3%3.2%
ROEProfit as a percentage of shareholders' money (from the March balance sheet).3.4%-9.1%11.1%
ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'.5.6%6.8%4.5%12.2%
Debt to equityBorrowings divided by shareholders' money. Lower is safer.0.00x0.00x0.00x0.00x
Interest coverHow many times operating profit covers the interest bill. Higher is safer.1.6x-2.8x3.3x

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 3,933 Cr of assets. Its owners funded 50% of that, with no borrowings.

What it owns
35%
12%
42%
Plant, property and projects350 Cr
Goodwill and intangibles49 Cr
Inventory1,382 Cr
Owed by customers27 Cr
Cash and bank462 Cr
Everything else1,662 Cr
How that is paid for
50%
42%
Shareholders1,975 Cr
Owed to suppliers307 Cr
Other liabilities1,651 Cr
Cash and equivalents
Rs 198 Cr
Net debt
Rs -198 Cr
more cash than debt
Current ratio
3.00x
short-term assets per rupee due soon
Book value / share
Rs 164
Return on assets
5.3%
EV / EBITDA
10.5x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 496 Cr, spent Rs 123 Cr on plant and equipment, and cash rose by Rs 112 Cr over the year.

From running the business
+496 Cr
Spent on or received from investing
-128 Cr
From or to lenders and shareholders
-256 Cr
Net change in cash
+112 Cr
Cash from operations for every Rs 100 of profit
Rs 180
FY23
Rs 219
FY24
Rs 116
FY25
Rs 226
FY26

Rs 100 or more means every rupee of reported profit arrived as cash.

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Retailing · 59
P/E34.71vs 42.47 median
Cheapest: OSIAHYPER 1.47Priciest: ETERNAL 614.25
Net margin2.91%vs 3.44% median
Lowest: URBANCO -24.39%Highest: NAUKRI 56.6%
Revenue growth21.84%vs 13.12% median
Lowest: SHANKARA -78.69%Highest: ETERNAL 77.62%

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Retailing · 40 shown
Company
ETERNAL
ETERNAL LIMITED
3.00 L cr614.3x9.6x1.6%-0.000.6%+77.6%0.00%
DMART
Avenue Supermarts Limited
2.05 L cr65.9x7.9x11.9%-0.164.2%+17.8%0.00%
TRENT
Trent Limited
1.47 L cr59.9x21.0x25.5%28.2%0.078.7%+17.8%0.12%
LENSKART
Lenskart Solutions Limited
1.13 L cr170.5x13.0x7.5%7.3%0.026.9%-0.00%
MEESHO
Meesho Limited
99,012 cr-22.6x--27.0%0.00--0.00%
NYKAA
FSN E-Commerce Ventures Limited
94,495 cr370.6x65.7x17.3%24.1%0.502.4%+29.1%0.00%
SWIGGY
Swiggy Limited
48,667 cr-2.9x-21.1%-0.00-13.3%+36.1%0.00%
VMM
Vishal Mega Mart Limited
41,554 cr46.4x5.3x11.4%-0.006.5%+14.0%0.00%
URBANCO
Urban Company Limited
20,113 cr-10.2x-23.1%-0.00-24.4%+41.4%0.00%
NAUKRI
Info Edge (India) Limited
15,506 cr48.5x0.4x4.7%4.7%0.0056.6%+11.4%3.51%
CARTRADE
Cartrade Tech Limited
13,553 cr61.0x5.5x9.7%11.0%0.0031.4%+16.3%0.00%
MANYAVAR
Vedant Fashions Limited
11,699 cr30.3x6.0x19.6%22.3%0.0026.5%+7.2%1.66%
INDIAMART
Indiamart Intermesh Limited
9,388 cr19.1x3.9x20.6%21.6%0.0030.6%+11.4%3.20%
ABLBL
Aditya Birla Lifestyle Brands Limited
8,505 cr48.4x6.0x12.5%13.2%0.592.0%+11.2%0.00%
FIRSTCRY
Brainbees Solutions Limited
7,966 cr-1.6x-3.4%-0.1%0.11-2.1%+13.1%0.00%
MEDPLUS
Medplus Health Services Limited
7,306 cr34.7x3.7x10.7%12.2%0.002.9%+21.8%0.00%
AVL
Aditya Vision Limited
7,230 cr52.1x10.5x20.2%21.7%0.484.8%+26.9%0.17%
ENTERO
Entero Healthcare Solutions Limited
6,420 cr51.3x3.8x9.6%11.6%0.322.4%+38.2%0.00%
VMART
V-Mart Retail Limited
6,165 cr44.8x6.5x14.5%14.5%0.113.5%+23.0%0.00%
EMIL
Electronics Mart India Limited
6,010 cr29.1x3.7x12.7%10.3%0.552.6%+39.1%0.00%
JUSTDIAL
Just Dial Limited
5,943 cr11.3x1.2x9.9%11.6%0.0040.5%+9.9%0.00%
ABFRL
Aditya Birla Fashion and Retail Limited
4,831 cr-0.8x-13.5%-3.2%0.27-10.1%+10.6%0.00%
ARVINDFASN
Arvind Fashions Limited
4,797 cr40.1x5.1x16.1%21.4%0.463.4%+15.5%1.49%
SHOPERSTOP
Shoppers Stop Limited
3,676 cr-12.6x-11.9%7.6%0.81-0.7%+11.2%0.00%
RTNINDIA
RattanIndia Enterprises Limited
3,185 cr-4.1x-85.0%---8.5%-19.1%0.00%
STYLEBAAZA
Baazar Style Retail Limited
2,769 cr57.8x6.2x10.4%13.6%0.772.4%+28.7%0.00%
CRIZAC
Crizac Limited
2,437 cr11.1x4.2x37.0%47.7%0.0021.2%-4.0%5.75%
GOCOLORS
Go Fashion (India) Limited
1,341 cr25.5x1.9x7.7%11.5%0.006.4%+0.0%0.00%
MATRIMONY
Matrimony.Com Limited
1,055 cr24.0x5.1x21.8%19.9%0.009.4%+13.2%2.04%
KALAMANDIR
Sai Silks (Kalamandir) Limited
996 cr7.3x0.8x10.8%13.7%0.028.3%-1.0%1.48%
PATELRMART
Patel Retail Limited
778 cr17.9x2.1x11.4%15.8%0.343.5%+69.7%0.00%
V2RETAIL
V2 Retail Limited
588 cr4.5x0.7x19.8%20.6%0.285.2%+57.7%0.00%
MUFTI
Credo Brands Marketing Limited
447 cr10.3x1.0x9.9%13.4%0.007.3%+4.4%4.39%
SHANKARA
Shankara Building Products Limited
272 cr54.6x0.6x1.1%4.7%0.430.4%-78.7%2.68%
TCC
TCC Concept Limited
195 cr-0.1x-4.0%0.01--0.00%
BCONCEPTS
Brand Concepts Limited
192 cr192.0x2.3x1.2%11.6%1.640.3%+11.0%0.00%
ISFT
Intrasoft Technologies Limited
167 cr12.2x0.6x5.1%5.5%0.062.5%+8.3%0.00%
SPENCERS
Spencer's Retail Limited
147 cr--27.2%-43.8%--13.4%+12.9%0.00%
DIGIDRIVE
Digidrive Distributors Limited
67 cr11.6x0.3x2.1%2.5%0.0012.3%+6.8%0.00%
PRAXIS
Praxis Home Retail Limited
65 cr----65.0%--+13.2%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
3 years · 18 quarters
Full financial years - the long arc of the business.
Sales growth
-
a year, 3 years
Profit growth
-
a year, 3 years
Operating margin
8.8%
latest year
Sales by financial yearRs 6,893 Cr
Net profit by financial yearRs 220 Cr
FY233 full years · hover a yearFY26

Operating margin has gone from 5.8% to 8.8% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 27 Oct
RSI (14) - momentum
44.7Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
49.8%Near average
today 49.8%20d avg 58.8%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-4.34%
vs 200-DMA
-20.92%
1-month
-5.01%
3-month
-13.31%
1-year
-18.61%
Realized vol (30d)
16.6%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on MEDPLUS?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.